Tumor antigen processing and presentation on MHC class II molecules for CD4+ T cell recognition in health and disease
Animal models have shown that CD4+ T cells are required to achieve effective, longlasting immunity to cancer. Less is known on the role and functional state in human disease of tumor antigen specific CD4+ T cells. These cells recognise epitopes from tumor antigens presented by MHC-II molecules on pr...
Main Author: | Marturano, Jill |
---|---|
Published: |
Open University
2007
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.486517 |
Similar Items
-
Detection and quantitation of tumor specific antigens
by: Moore, Valerie Elizabeth
Published: (1978) -
Major histocompatibility complex class II molecules : importance in early T cell infiltration and use in the identification of immunologically relevant peptides
by: Imlach, Stuart Nicolson
Published: (1998) -
Development of a dendritic cell-based vaccine to enhance CD4+ T-cell responses to a breast tumour antigen
by: Carter, Joanne Louise
Published: (2000) -
Tumour immunity and MHC class I associated phosphopeptides
by: Penny, Sarah Amy
Published: (2014) -
Therapeutic gene transfer for malignant melanoma : augmentation of direct versus indirect tumour antigen presentation
by: Thirdborough, Stephen M.
Published: (1998)